Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

Inborn errors of metabolism and rare genetic diseases
Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)
Phenylketonuria (PKU) and organic acidurias
Neonatal screening programs
Epidemiology and real-world evidence in pediatric metabolic disorders
Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

Principal Investigator in multiple national and international clinical trials
Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD
Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN
Co-author of educational and clinical monographs, including:
- “Inherited Metabolic Disorders Neonatal Screening” (2014)
- Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)
- Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Posted on 07/05/202507/05/2025 by ScienceFather

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.
3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.
“Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.
“Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.
“Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.
“Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.
“Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.
“Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.
“Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Posted on 28/04/202528/04/2025 by ScienceFather

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics 🧪. With a Master’s in Pharmacology 🎓 and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing 📚. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams 👩‍🔬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer 📝. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication 💪, and innovation 💡. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer 🖋️ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles 📄, pharmacological monographs 📑, systematic reviews 📚, and regulatory documents 🏛️. She specialized in herbal medicine 🌿, clinical data analysis 📊, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor 🎓 at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching 📚, mentoring students 🎯, curriculum development ✍️, and academic research 🧪. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🤝, reviewed manuscripts for leading journals 📰, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor 🔬, exceptional communication skills 🗣️, and regulatory precision 📏, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence 📚, leadership 🏅, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer 🖊️ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎤 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” 🔬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion 🏆 of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi 🎓. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics 💊. She has explored the anti-diabetic 🌟, anti-inflammatory 🧪, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments 🧘‍♀️ through evidence-based studies, clinical evaluation 📊, and data synthesis from ethnobotanical sources 📚. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication 🖋️, regulatory documentation 📑, and the development of novel therapeutics 🚀, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

📄 Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.
📄 Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.
📄 Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.
📄 Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.
📄 Elevating the Inner-Consciousness “Third Eye” Through “Vedic Manas Yoga” Practice.
📄 Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

📚 Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.
📚 Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.
📚 Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.
📚 Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.
📚 Impact of Biosensors and Biomarkers in Diabetes Care: A Review.
📚 Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.
📚 Effect of Coliform Bacteria on Various Environmental Factors: A Review.
📚 Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.
📚 Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.
📚 Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Posted on 22/04/202522/04/2025 by ScienceFather

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Prevalence of unintended pregnancy in the MENA region: a systematic review and meta-analysis

Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis

Cross-cultural adaptation: South African Gestational Diabetes Mellitus Knowledge Questionnaire

Prevalence and factors associated with falls in older adults in a Middle Eastern population: a retrospective cross-sectional study

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010–2023—A systematic review and meta-analysis

Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Posted on 13/03/202513/03/2025 by ScienceFather

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Posted on 12/03/202512/03/2025 by ScienceFather

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Assoc. Prof. Dr Lucia Ciranna, Università di Catania, Italy

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her groundbreaking research on the serotonin brain system, Fragile X Syndrome, and neurodevelopmental disorders. With a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg (1995) and a Pharmacy degree from the University of Catania (1989), she has significantly advanced understanding of neurological diseases. As an Associate Professor of Physiology at the University of Catania since 2006, she has led innovative studies on neurodevelopment and therapeutic interventions. Her extensive research contributions, spanning over three decades, have earned her prestigious qualifications in France and Italy. Dr. Ciranna’s work has been instrumental in exploring the therapeutic potential of serotonin modulation, glial interactions, and receptor mechanisms in neurological disorders. Her prolific publication record and dedication to advancing neuroscience make her a deserving recipient of the Women Researcher Award. 🧠📚🏅

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist with a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg, France (1995) 🧠, where she focused on serotonin neurotransmission and neurodevelopment. She earned her Pharmacy degree from the University of Catania (1989) 💊, specializing in neuropharmacology and brain physiology. Her postdoctoral research at the University of Catania (1995-1998) 🔬 explored serotonin’s role in synaptic plasticity and cognition. Further advancing her expertise, she trained in molecular neuroscience and pharmacology (1998-2000) 🎓. Dedicated to lifelong learning, she actively engages in international neuroscience workshops and research collaborations 📖.

Experience

Assoc. Prof. Dr. Lucia Ciranna is a distinguished physiologist at the University of Catania (2006-Present) 🏫, leading groundbreaking research on serotonin’s role in neurological disorders and innovative therapeutic strategies. Previously, she was a researcher at the same institution (1994-2006) 🔬, investigating neurophysiology in cognitive impairments and receptor signaling. She earned her Ph.D. from Louis Pasteur University of Strasbourg (1990-1994) 🎓, focusing on neurodevelopmental mechanisms and serotonin modulation in brain function. Earlier, she contributed to neuropharmacology research at the University of Catania (1989-1990) 🧬. As a scientific collaborator with international neuroscience labs 🌍, she continues exploring cutting-edge advancements in the field.

Awards and Honors

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her contributions to neurophysiology 🧠. She achieved the Qualification to the function of Professeur des Université in France (2012) 🇫🇷 and later became a Professore Ordinario (Full Professor of Physiology) in 2018 🎓. Her research has been supported by prestigious international neuroscience grants 💰, driving innovation in the field. A sought-after speaker, she has delivered distinguished lectures at major neurophysiology conferences worldwide 🎤. Dr. Ciranna’s groundbreaking work on Fragile X Syndrome has earned her accolades for excellence in neurodevelopmental research 🏅.

Presentation

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist specializing in serotonin receptor modulation and its implications for neurodevelopmental disorders 🧠🔬. She has delivered numerous invited seminars and conference presentations worldwide, focusing on the role of 5-HT7 serotonin receptors in synaptic plasticity, cognition, and behavior. Her research explores therapeutic strategies for Fragile X Syndrome and Autism Spectrum Disorders, with key contributions to understanding serotonin-mediated neuromodulation 🎓🧪. Dr. Ciranna has also engaged in public science communication, appearing on RAI Telethon broadcasts 📺. Her work continues to shape novel approaches for treating cognitive disorders through serotonin receptor activation. 🌍📚

Research Focus

Assoc. Prof. Dr. Lucia Ciranna is dedicated to unraveling the complexities of the serotonin brain system 🧠, exploring its role in neurological disorders and potential therapeutic interventions. Her research focuses on Fragile X Syndrome 🧬, aiming to develop targeted treatments for cognitive deficits. She investigates neurodevelopmental disorders 💡, shedding light on autism, intellectual disabilities, and brain dysfunctions. Her work also delves into glial-neuronal interactions 🤝, examining their impact on neurodevelopment and inflammation. Passionate about therapeutic innovations in neuroscience 🏥, she seeks novel drug targets and treatment strategies to improve neurological health and patient outcomes.

Publication Top Notes

Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells

Editorial: Role of glia in neurodevelopmental disorders

Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease

Purinergic ionotropic P2X7 and metabotropic glutamate mGlu₅ receptors crosstalk influences pro-inflammatory conditions in microglia

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Posted on 07/03/202507/03/2025 by ScienceFather

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. 🏅📚🔬

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok 🎓 pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) 🏥📖, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) 🎓🩺. He further obtained a DNB (ENT) in 2021 🏅📚 and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 🎧🔬. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. 📘💉🔍

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) 🏨👨‍⚕️ and Malabar Cancer Centre, Kerala (2021-2022) 🎗️🏥, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) 🎓📖, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) 🏨🩺 and Azeezia Health City, Palakkad (2025-Present) ⚕️🔬. His dedication to patient care and surgical excellence makes him a respected figure in the field. 🏆👨‍⚕️

Awards & Honors

Dr. Vivekanand Ashok’s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) 🥉🧠, demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award 🎖️📖, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. 🏆🔬

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. 🎧👂📊

Publication Top Notes

Unmasking the Fungal Menace: A Case Report of Chronic Granulomatous Invasive Fungal Sinusitis of Maxilla

Clinical features, diagnosis, and treatment outcome of Rhino-orbito-cerebral mucormycosis: A 2-year experience at a tertiary care center

Extrapulmonary head and neck tuberculosis: 3 year experience at a tertiary care centre

Nasal haemangioma as a cause of epistaxsis: a case report

Laryngopharyngeal reflex – Diagnosis and management at atertiary care centre

Nasal cavity extramedullary plasmacytoma: literature review and clinical experience

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Posted on 24/02/202524/02/2025 by ScienceFather

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Dr GORDON WEST, Pacific Lutheran University School of Nursing – Tacoma, WA, United States

Dr. Gordon West is a dedicated nurse scientist and healthcare leader with a PhD from the Uniformed Services University (2016) 🎓. He holds an MHA from Baylor University (2006) and a BSN from McMurry University (1998) 🏥. Currently, he is a Research Nurse at The Geneva Foundation-Madigan and an Assistant Professor at Pacific Lutheran University 📚. With vast experience in military and civilian healthcare, he has led numerous research projects on infection control, patient safety, and military health 🩺. A Fellow of the American College of Healthcare Executives, he has received multiple awards for nursing research and excellence 🏆.

Publication Profile

Google Scholar

Education

Dr. Gordon West 🎓 is a dedicated healthcare professional with a strong academic background. He earned his Ph.D. in 2016 from the Uniformed Services University of the Health Sciences 🏥 in Bethesda, MD. Prior to that, he completed his Master of Healthcare Administration (MHA) in 2006 at Baylor University 🏛️ in Fort Sam Houston. His journey in healthcare began with a Bachelor of Science in Nursing (BSN) from McMurry University 🎓 in Abilene, TX, in 1998. With extensive education and expertise, Dr. West continues to contribute to the field of healthcare and administration with passion and dedication. 💉📚

Experience

Dr. Gordon West is a dedicated Research Nurse 🩺 at The Geneva Foundation – Madigan (2023-present) and an Assistant Professor 📚 at Pacific Lutheran University (2022-present). He actively contributes as a Research Board Member at the Washington State Nursing Association & Health Care Council and a Board Member at Rainer Olympic Nurses Association. His extensive military nursing career includes leadership roles at Madigan AMC, Tripler, and Fort Belvoir 🏥, alongside international service in Korea 🇰🇷 and Iraq 🇮🇶. A Ph.D. graduate from USUHS 🎓, he also teaches at Maryville University and Central Michigan University, shaping future nursing professionals. 🌟

Awards & Honors

Dr. Gordon West has been recognized for his outstanding contributions to nursing and healthcare research 🏥📚. In 2023, he received a Daisy Nomination from Pacific Lutheran University for his dedication to patient care and nursing excellence 🌿🏆. In 2019, he was honored with the ANCA Nursing Research Award by the Army Nurse Corps Association, highlighting his impactful research in military nursing 🎖️🔬. That same year, he also received the Excellence in Nursing Research Award from the Defense Health Agency, acknowledging his commitment to advancing healthcare through evidence-based practices and innovation 🏅💡.

Research Focus

Dr. Gordon B. West’s research explores critical language pedagogy 🎓📖, focusing on morality, identity, and power in neoliberal English language education 🌍💬. His work critically examines good teacher identities in South Korea 🇰🇷, the politicization of language educators 🗣️⚖️, and the emotional complexities of critical pedagogy ❤️🧠. He also investigates sociohistorical perspectives on literacy 📚⏳ and the challenges of critical practitioner research under difficult conditions 🔍🛠️. Through qualitative and materialist approaches, Dr. West sheds light on language education as both a tool for liberation and oppression ✊🔗, emphasizing the impact of neoliberalism on English teaching 💵🏫.

Presentation

Dr. Gordon West is a dedicated nursing researcher focusing on infection control 🦠, patient safety 🏥, and healthcare communication 📢. He has presented extensively, including at the Phyllis J. Verhonick Conference (2016) on patient education and fall prevention 🩺. His work on bacterial contamination of hospital uniforms led to multiple presentations at the American Organization of Nurse Executives Conference (2016-2017) and the Sigma 29th International Nursing Research Conference in Melbourne (2018) 🌏. He also explored hands-free communication in nursing at TSNRP (2017). His research enhances clinical safety, infection prevention, and nurse satisfaction, shaping better healthcare practices globally 🌍.

Publication Top Notes

Navigating morality in neoliberal spaces of English language education

Young learners’ portrayals of ‘good English teacher’identities in South Korea

Critical practitioner research in language education under difficult circumstances

“How did you become political?”: Narratives of junior researcher-practitioners in applied linguistics

“Is this a safe space?”: Examining an emotionally charged eruption in critical language pedagogy

Literacy is a Sociohistoric Phenomenon with the Potential to Liberate and Oppress

Doing critical language pedagogy in neoliberal spaces: A materialist narrative analysis of teaching young learners of English in a Korean hagwon

Positioning of female marriage immigrants in South Korea: a multimodal textbook analysis

Hsiang-Chu Pai | Medicine and Health Sciences | Best Researcher Award

Posted on 04/02/202504/02/2025 by ScienceFather

Hsiang-Chu Pai | Medicine and Health Sciences | Best Researcher Award

Prof Hsiang-Chu Pai, Chung Shan Medical University, Taiwan

Prof. Hsiang-Chu Pai, Ph.D., is a distinguished professor at the Department of Nursing, Chung Shan Medical University, Taiwan. With a background in nursing education and research, she holds a Ph.D. and MS in Nursing from Chung Shan Medical University and a BS in Nursing from Kaohsiung Medical University. Her research focuses on medical and surgical nursing care, home care, nursing education, evidence-based health care, and hospice and palliative nursing. She has received multiple honors, including the 2018 Award for Excellence in Teaching. Her publications address topics like stroke care and healthcare student communication. 🏥📚💉👩‍⚕️

Publication Profile

Scopus

Education

Prof. Hsiang-Chu Pai is an accomplished academic in the field of nursing. She holds a Ph.D. and an M.S. in Nursing from Chung Shan Medical University, Taiwan, and a B.S. in Nursing from Kaohsiung Medical University, Taiwan. With her extensive academic background, Prof. Pai has contributed significantly to nursing education and research. Her dedication to advancing the field of nursing through both teaching and research has made her a prominent figure in Taiwan’s healthcare education system. 🌟📚👩‍⚕️

Research Interests

Prof. Hsiang-Chu Pai is a distinguished expert in medical and surgical nursing care, particularly in stroke management 🧠. With a passion for home care 🏡, nursing education 📚, and evidence-based health care 🏥, she has dedicated her career to improving patient outcomes. Her work also extends to hospice and palliative nursing 🕊️, ensuring compassionate end-of-life care. Prof. Pai’s contributions have significantly shaped nursing practices, promoting the integration of research findings into everyday care. She continues to inspire healthcare professionals with her commitment to advancing nursing through education and evidence-based approaches. 💉👩‍⚕️

Honors and Awards

Prof. Hsiang-Chu Pai is a distinguished educator, recognized for her commitment to teaching excellence. In 2018, she was honored with the Award for Excellence in Teaching by Chung Shan Medical University 🎓🏆. Her dedication to nursing also earned her the prestigious B. Braun Nursing Paper Award in 2005, presented by the Taiwan Nurses Association 🏅💉. With a wealth of experience in academia and nursing, Prof. Pai continues to inspire and contribute significantly to the field of healthcare education. Her accolades reflect her passion for nurturing future professionals in the medical and nursing sectors. 👩‍⚕️📚

Research Focus

Prof. Hsiang-Chu Pai’s research focuses on improving healthcare practices and outcomes through interdisciplinary approaches. His work examines the impact of health humanities, such as the role of comics and community dialogue, on empathy and communication skills among healthcare students. Additionally, Prof. Pai explores psychological well-being, workplace resilience, and stress among healthcare workers, particularly in long-term care institutions. His studies also address the caregiving experience, including family dynamics in stroke recovery and moral distress in nursing. Overall, his research aims to enhance healthcare delivery, patient care, and professional development in nursing and related fields. 📚💉👩‍⚕️💪

Publication Top Notes

The effect of comics and Interprofessional community dialogue on health humanities, empathy, and communication among healthcare students

Effects of a nurse-led therapeutic conversations intervention in stroke patient–family caregiver dyads: A randomized control trial

Examining the Factors Affecting Psychological Well-Being in Certified Nurse Aides Working at Long-Term Care Institutions

Workplace Resilience and Stress Among Certified Nursing Assistants in Long-Term Care Institutions During the COVID-19 Pandemic

Association Between Family Functioning and Health-related Quality of Life in Stroke Survivor–Informal Family Caregiver Dyads

Effects of Professional Growth-Need Strength on Nursing Competencies: A Care-Task Design and Clinical Reasoning Program

The moral distress, protective factors, and resilience: the role of ethical decision-making competence among student nurses

Factors associated with facial pressure injury in patients receiving non-invasive positive pressure ventilation mask: A retrospective case–control study

Predictive Factors of Apathy in Stroke Survivors During the Recovery Period

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Posted on 11/12/202411/12/2024 by ScienceFather

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yasser Khazaal, Lausanne university, Switzerland

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist and researcher with extensive experience in addiction psychiatry. He earned his MD from René Descartes, Paris V, and Swiss Board Certification in Psychiatry and Psychotherapy. Currently, he is a Full Professor at the University of Lausanne, Switzerland, and holds multiple roles including Associate Researcher at Montreal University. Prof. Khazaal’s research focuses on cognitive behavioral therapies, game-based interventions, and the development of smartphone apps for addiction treatment. He has published extensively on addictive disorders and is a key figure in international psychiatric societies. 🏥📚🔬

Publication Profile

google scholar

Education

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist with an impressive academic background. He earned his MD from René Descartes, Paris V, France, in 1998. In 2005, he achieved Swiss Board Certification in Psychiatry and Psychotherapy. His expertise and contributions were further recognized with his appointment as a Privat Docent (senior lecturer) at Geneva University in 2009. Dr. Khazaal is known for his work in psychiatry and psychotherapy, holding a prominent position in the academic and clinical communities in Switzerland. 🌐🩺📚

Employment History

Prof. Dr. Yasser Khazaal has an extensive background in addiction psychiatry. From 2003 to 2005, he served as a senior psychiatrist and head of the mood and anxiety disorders outpatient unit at Lausanne University Hospital. From 2007 to 2018, he was the deputy head of the Addiction clinic at Geneva University Hospitals. Over the years, he held successive academic appointments at Geneva University, Switzerland, eventually becoming a full professor of addiction psychiatry at the Faculty of Biology and Medicine, University of Lausanne since 2019. He is also a member of the board of Addiction medicine at Lausanne University Hospital. Prof. Khazaal is an associate researcher at the Montreal University Institute of Mental Health, Canada, and an associate professor at the Department of Psychiatry and Addiction, Montreal University, Canada. Additionally, he served as a visiting professor at Kazimierz Wielki University, Poland, in 2022, as part of a project co-financed by the European Union. 📘🔍🌍

Teaching

Prof. Dr. Yasser Khazaal has extensive experience in teaching medical students at both the University of Lausanne (2003-2007, 2019-2023) and the University of Geneva (2007-2018). His teaching portfolio includes courses on mood and anxiety disorders (2003-2007), psychopharmacology (2006-2007), addiction (2019-2023), and community research in practice (2021-2023). He has also taught and supervised clinical cognitive and behavior therapy (CBT) skills (2018-2023), CBT for bipolar disorder (2007), CBT for mood disorders (2005-2006), and CBT of impulsive behaviors (2020). Prof. Dr. Khazaal is committed to integrating clinical teaching and practice in his courses. 📚💬🧠

Grants

Prof. Dr. Yasser Khazaal is a leading researcher in addiction and mental health, with extensive funding from various Swiss and international sources. His projects include studies on cognitive behavioral interventions for psychosis, mood and anxiety disorders, smoking cessation, and smartphone applications for addiction treatment. Key grants include the Swiss National Science Foundation (268,426 CHF) and Astra-Zeneca (140,000 CHF) for LACOSMA, as well as research on “Impact of Pick Klop game on smoking cessation” (172,500 CHF) and smartphone applications (194,942 CHF). He collaborates internationally on projects such as managing trauma exposure in Congo (12,125 Euros) and the “Sesame” serious game for mental health (20,000 CHF). His work continues to advance the field with a focus on innovative and practical solutions to addiction and mental health challenges. 🧠💊🚬

Conferences and Awards

Prof. Dr. Yasser Khazaal is a distinguished academic and leader in the field of social psychiatry. He served as the Chair for the European Congress of Social Psychiatry in 2012, 2015, and 2018. He was also the Co-chair for the International Conference of Behavioral Addictions in 2016, held in Geneva, Switzerland. More recently, he co-chaired the Challenges of Ecology Related to Mental Health conference in Athens in 2022. In recognition of his contributions, he was elected an Honorary Fellow of the World Association of Social Psychiatry in 2013. 🌍🔍💬

Scientific Achievements

Prof. Dr. Yasser Khazaal is a renowned expert in addiction studies, focusing on game-based interventions, including delusions and smoking cessation. He has contributed significantly to the development of smartphone app interventions for addictive disorders and mood regulation. Prof. Khazaal has published extensively on the assessment and psychopathology of addictive disorders. He also leads research on Recovery Oriented Services, exploring community interventions and peer support initiatives. 🌱📱🚭📚

Research Focus

Yasser Khazaal is a researcher primarily focused on behavioral addictions, particularly in the context of online gaming and internet use. His work explores how common behaviors can become problematic without necessarily being pathologized as addiction. He investigates self-reported motivations behind playing online games, such as World of Warcraft, and examines problematic involvement in these games using various psychological and survey methods. Khazaal’s research aims to refine the understanding of behavioral addiction and its implications for mental health, with a particular interest in the validation and adaptation of assessment tools for addictive behaviors in digital environments. 💻🕹️📊